Pharmaceutical firm Acquired biotech or pharmaceutical firm Year Financial amount Takeda Pharmaceutical Millennium Pharmaceuticals 2008 880 billion JYN Nycomed International Management 2011 1100 billion JYN Eisai MGI Pharma 2008 410 billion JYN AstellasPharma OSI Pharmaceuticals 2010 370 billion JYN Daiichi Sankyo Ranbaxy Laboratories 2008 480 billion JYN Plexxikon 2011 66 billion JYN Shionogi ScielePharma 2008 150 billion JYN Sumitomo Dainippon Pharma Sepracor 2009 250 billion JYN

Table 1: Selected examples of Japan’s pharmaceutical firms’ M&As (Data: selected from [8]).